Pacemaker implantation is one of the safer procedures in cardiology, and that holds true even for patients in their eighties and nineties. Large database studies show that in-hospital mortality for patients over 90 is under 2%, and device-related complication rates in elderly patients are often no higher than in younger ones. The real question is not whether the surgery is dangerous because of age alone, but whether a particular patient’s overall health makes the procedure riskier than average.
What the Complication Rates Actually Look Like
One of the most counterintuitive findings in the pacemaker literature is that older patients sometimes have fewer complications than younger ones. A study comparing elderly patients (over 65) with younger patients found a complication rate of about 8% in the older group versus 15% in the younger group, a statistically significant difference that went in the opposite direction many people would expect.1PubMed Central. Pacemaker implantation complication rates in elderly and young patients Researchers have speculated this may reflect more careful patient selection and more conservative surgical approaches in older patients, though the exact reasons are still debated.
For the very old, the numbers remain reassuring. A nationwide analysis of U.S. hospital data found that patients aged 70 to 79 had an in-hospital mortality rate of about 0.6% and a complication rate of roughly 5.6%. For patients over 90, mortality was about 1.9% and complications around 6.3%.2PubMed. Safety of pacemaker implantation in nonagenarians: an analysis of the healthcare cost and utilization project-nationwide inpatient sample That is a real increase with age, but both numbers are still low in absolute terms. A separate study comparing patients younger and older than 85 found that over two years, the rates of death or severe complications were essentially identical between the two groups.3PubMed. Comparison of prognosis and safety of pacemaker implantation in patients aged less than or 85 years and older
Even pacemaker replacement surgery, which some patients in their nineties need when an older battery runs out, appears to be safe. A study of nonagenarians undergoing pacemaker replacement found the average procedure lasted about 35 minutes, the average hospital stay was just over two days, and only one patient died from a complication related to the procedure.4PubMed. Pacemaker replacement in nonagenarians: Procedural safety and long-term follow-up
The Specific Complications to Know About
When complications do occur, they tend to fall into a few categories. Pocket hematoma, which is a collection of blood at the site where the device sits under the skin, is one of the most common. It is uncomfortable and can extend the hospital stay but is rarely life-threatening on its own. Pneumothorax, where air leaks into the space around the lung during the procedure, is another recognized risk and is somewhat more likely in patients over 80 and in those with a history of chronic lung disease.5PubMed Central. Subacute pacemaker lead migration with cardiac perforation and extracardiac extension into lung parenchyma with associated pneumothorax
Cardiac perforation, where a pacemaker lead pokes through the heart wall, is rare but serious. Risk factors for this include older age, low body mass index (under 20), steroid use in the week before implantation, and certain lead designs.5PubMed Central. Subacute pacemaker lead migration with cardiac perforation and extracardiac extension into lung parenchyma with associated pneumothorax Extremely rare lead malpositions have also been documented, such as a case where a lead exited one blood vessel and re-entered another, causing significant bleeding.6PubMed Central. Case Report: Electrode perforation with normal pacemaker parameters leading to hemorrhagic shock: a rare case report of the “penetration-exit-re-entry” phenomenon These case reports make headlines but represent the tail end of risk.
Infection is a more practical concern for older patients. Research has shown that aging itself may independently raise the risk of infection after pacemaker implantation, likely because immune function declines with age.7PubMed Central. Aging Might Increase the Incidence of Infection from Permanent Pacemaker Implantation Device infections, while uncommon, are serious because they can require removal of the entire pacemaker system and prolonged antibiotic treatment. This is one area where age does matter, and hospitals take preventive measures like antibiotic dosing before the procedure to reduce this risk.
Blood Thinners Are a Bigger Deal Than Age
Many elderly patients take anticoagulants or blood thinners for conditions like atrial fibrillation, artificial heart valves, or a history of blood clots. Managing these medications around a pacemaker implantation is one of the trickiest aspects of the procedure in older adults, and it matters more to your complication risk than how old you are.
The issue is straightforward: stop the blood thinner and you risk a stroke or clot, but operate while on it and you risk excessive bleeding at the surgical site. One study found that patients who stopped warfarin and were temporarily switched to injectable blood thinners (a practice called bridging) had a dramatically higher rate of pocket hematomas compared to those who did not need bridging, roughly 27% versus under 1%.8Heart, Lung and Circulation. Peri-procedural Anticoagulation and the Incidence of Haematoma Formation after Permanent Pacemaker Implantation in the Elderly Most of the hematomas developed when the injectable blood thinner was restarted within 24 hours of the procedure. Another study found that warfarin use was significantly linked to hematoma formation, while aspirin and clopidogrel alone did not meaningfully raise the risk.9PubMed. Hematoma complicating permanent pacemaker implantation: the role of periprocedural antiplatelet or anticoagulant therapy
Current practice at many centers now favors performing the implantation while continuing warfarin rather than bridging to injectable anticoagulants, since continuous warfarin produces fewer bleeding events than the bridging strategy. Patients on newer oral blood thinners like dabigatran appear to have hematoma rates similar to those on warfarin, with no significant difference between the two in at least one study of elderly patients.10PubMed Central. Pacemaker Implantation in Elderly Patients: Safety of Various Regimens of Anticoagulant Therapy If you or a family member are on blood thinners, the conversation with the cardiologist about how to handle them around the procedure is one of the most important you will have.
Frailty Matters More Than the Number on Your Birthday
Doctors have increasingly recognized that chronological age is a poor predictor of surgical risk on its own. A vigorous, independent 88-year-old and a frail, homebound 88-year-old face very different odds from the same operation. The concept that captures this distinction is frailty, which encompasses things like muscle weakness, exhaustion, slow walking speed, and the accumulation of multiple chronic conditions.
Research backs this up in hard numbers. One study found that clinical frailty scores independently predicted long-term death and heart failure hospitalization after cardiac device implantation, even after adjusting for age.11Circulation Journal. Clinical Frailty Score Predicts Long-Term Mortality and Hospitalization Due to Heart Failure After Implantation of Cardiac Implantable Electric Device A nationwide analysis found that patients at high risk of frailty had roughly six times the in-hospital mortality of patients at low risk, along with longer hospital stays and higher costs.12Heart Rhythm O2. Association between frailty and in-hospital outcomes in patients undergoing leadless pacemaker implantation: A nationwide analysis That is a much bigger risk multiplier than age itself.
Kidney disease is another independent predictor that deserves attention. In elderly patients with pacemakers, having significantly reduced kidney function (an estimated filtration rate below 45) was associated with worse survival over the long term.13PubMed Central. Impact of chronic kidney disease on mortality in older adults treated with pacemaker implantation More strikingly, end-stage kidney disease pushes infection rates dramatically higher, to roughly 12.5% compared to 0.2% in patients without kidney disease, and bleeding complications climb as well.14Journal of Cardiovascular Electrophysiology. End-stage renal disease predicts complications in pacemaker and ICD implants For patients on dialysis or with severe kidney impairment, the risk calculation around pacemaker implantation is genuinely different from the general elderly population.
Gender Differences in Outcomes
Women face slightly higher complication rates from traditional pacemaker implantation than men, and this holds true regardless of age. A large quality-control analysis found that women had an overall complication rate of about 5.8% compared to 4.7% in men.15EP Europace. Do gender differences exist in pacemaker implantation?—results of an obligatory external quality control program The differences were driven specifically by pneumothorax, where women had about twice the odds of men, and pocket hematoma, where women had roughly 50% higher odds. The pneumothorax disparity may relate to anatomical differences in how the veins near the collarbone are accessed.
Interestingly, this gender gap may be narrowing with newer technology. A study of leadless pacemakers found that complication rates for women and men were similar across most measures, including access site bleeding, cardiac perforation, and 30-day readmission and mortality.16Circulation. Abstract 12244: Gender Differences in Leadless Pacemaker Peri-Procedural Adverse Events, Long-Term Device Functions, and Clinical Outcomes Since leadless pacemakers are delivered through a leg vein rather than a chest vein, the anatomy-related risks that disproportionately affect women are largely bypassed.
Leadless Pacemakers and Newer Approaches
Traditional pacemakers involve a small generator implanted under the skin near the collarbone, connected by one or two wires (leads) threaded through a vein into the heart. Each component is a potential point of failure: the pocket can get infected or bleed, the leads can fracture or shift position, and the chest vein can narrow over time. Leadless pacemakers, which are self-contained capsules placed directly inside the heart through a catheter inserted in the groin, eliminate the pocket and lead-related issues entirely.
For elderly patients specifically, the safety profile of leadless pacemakers appears comparable to conventional devices. A study of patients over 80 found no significant difference in procedure-related complications between leadless and traditional pacemakers, with rates of about 3% and 6% respectively.17PubMed. Safety of leadless pacemaker implantation in the very elderly A nationwide readmission analysis of nearly 50,000 admissions found that leadless pacemakers had significantly lower rates of device-related complications and device revision compared to conventional single-lead pacemakers in older adults.18EP Europace. Comparison of readmission outcomes and complications between leadless and traditional transvenous pacemakers in older adults: a nationwide readmission analysis of 49852 admission events Thirty-day readmission rates and mortality were similar between the two types.
There are limitations, though. Leadless pacemakers currently work best for single-chamber pacing, which is not suitable for every patient. Octogenarians may need more deployment attempts during the procedure, which slightly increases fluoroscopy time, though outcomes remain good overall.19PubMed Central. Efficacy and safety of leadless pacemaker implantation in octogenarians: a single-center experience A small case series documented successful use of leadless pacemakers in extremely elderly patients who already had an old conventional pacemaker system in place, avoiding the risks of extracting the old leads.20PubMed Central. Utilizing Leadless Pacemakers in Extremely Elderly Patients With a Conventional Pacemaker System: A Two-Year Follow-Up Case Series Without Generator Extraction in High-Risk Scenarios
Conduction system pacing is another newer technique that aims to stimulate the heart’s natural electrical pathway rather than just the muscle. Early results suggest that success rates and complication profiles are similar between elderly and younger patients undergoing this approach.21Scientific Reports. Feasibility, safety and outcomes of conduction system pacing for bradycardia amongst the very elderly For patients in whom leadless pacing is not appropriate, conduction system pacing offers another option that does not appear to carry additional age-related risk.
Life After the Pacemaker
The safety discussion often stops at the operating room door, but what happens afterward matters just as much. A scoping review found that pacemaker implantation generally improves quality of life in elderly patients, particularly in terms of cardiovascular function, mobility, and independence.22Indonesian Journal of Global Health Research. The Impact of Permanent Pacemaker Implantation on the Quality of Life in Elderly Patients: A Scoping Review That makes sense: the symptoms that led to the pacemaker, such as dizziness, fainting, fatigue, and shortness of breath, are exactly the symptoms that rob older adults of their independence.
Quality-of-life findings are somewhat mixed when you dig deeper. One study noted that older pacemaker recipients reported worse scores on measures of physical and emotional functioning, social interaction, and pain compared to younger recipients. But prior research had also shown that patients between 65 and 84 who were still cohabiting and living independently reported better quality of life than average, and that some elderly patients adapted better to life with a device because they had fewer competing demands on their physical capacity.23PubMed Central. Patient Perceptions and Quality of Life in Pacemaker Recipients The takeaway is that the pacemaker itself tends to help, but it does not erase the underlying burden of aging and other chronic conditions.
One practical challenge that families should plan for is remote monitoring. Modern pacemakers transmit data wirelessly to the cardiology team, which reduces the number of in-person visits required. However, conditions that are common in older adults, including dementia and depression, are associated with lower adherence to remote monitoring programs.24Heart Rhythm. Factors associated with remote monitoring adherence for cardiovascular implantable electronic devices If the patient has significant cognitive decline, a caregiver or family member needs to be involved in making sure the monitoring equipment stays connected and transmitting. Missed transmissions mean the care team cannot catch problems like lead malfunction or battery depletion early.
Urgent Implantation in the Very Old
Some pacemaker implantations are elective, meaning the patient and doctor can schedule the procedure at an optimal time. Others are urgent, prompted by a sudden dangerous drop in heart rate, a complete heart block, or repeated fainting episodes. There is a reasonable concern that urgent procedures in very old patients might carry higher risk because there is less time to optimize medications, manage blood thinners, or address other health issues beforehand.
Available evidence is encouraging. A study of elderly and very elderly patients undergoing urgent permanent leadless pacemaker implantation found no significant difference in complication rates at 12 months compared to conventional urgent pacemaker implantation.25Journal of Cardiovascular Medicine. Leadless pacemaker for urgent permanent implantation in elderly and very elderly patients A study of nonagenarians undergoing pacemaker implantation more broadly found that while about 17% had complications during their hospital stay, the vast majority of those were related to existing health conditions rather than the device itself. Only about 5% had device-related complications.26PubMed Central. Procedural safety and long-term follow-up after pacemaker implantation in nonagenarians This distinction matters because it tells you the surgery itself is not the main danger; the patient’s baseline health is.
When Not to Implant
The conversation about pacemaker safety in the elderly would be incomplete without acknowledging that sometimes the most important decision is whether to implant at all. For patients with terminal illness, advanced dementia, or a very limited life expectancy, the benefits of a pacemaker may be marginal while the burdens of hospitalization, recovery, and ongoing device management remain real.
Expert consensus supports the idea that patients have the right to decline a pacemaker, and that withdrawing pacemaker support in terminally ill patients is legally and ethically equivalent to withdrawing other forms of life-sustaining treatment.27PubMed. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life Death after pacemaker deactivation is considered attributable to the patient’s underlying condition, not to the act of turning off the device. A separate review confirmed that pacemaker deactivation, while sometimes unfamiliar to clinicians, is supported by expert guidelines and should be offered after thorough informed consent that includes a discussion of the patient’s values and goals.28PubMed. The ethics of pacemaker deactivation in terminally ill patients
These conversations ideally happen before the procedure, not after. If you are helping an elderly family member decide about a pacemaker, it is worth asking the cardiologist directly what the expected benefit is in terms of symptoms and survival for this specific patient, and what happens if they choose not to proceed. For many elderly patients, the pacemaker will genuinely reduce symptoms and help them stay active and independent. For a smaller subset, the procedure adds medical complexity to an already burdened final phase of life. Age alone should not drive either decision.